Definition
An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Top Gene Interactions
Related Pathways
Gliclazide Interacts with Diseases
Disease | Inference Score | References/Inference Genes |
Diabetes Mellitus, Experimental | 55.35 | |
Diabetes Mellitus, Type 2 | 49.35 | |
Reperfusion Injury | 45.95 |
References/Inference Genes
|
Hypertension | 34.92 |
References/Inference Genes
|
Brain Ischemia | 33.43 | |
Alcoholic liver cirrhosis | 33.18 |
|
Prostatic Neoplasms | 31.44 |
References/Inference Genes
|
Myocardial infarction | 29.01 | |
Alzheimer's Disease | 28.44 | |
Kidney Failure, Chronic | 26.24 | |
Diabetes Mellitus, Type 1 | 25.91 | |
Heart failure | 25.85 | |
Stomach Neoplasms | 25.73 | |
Cell Transformation, Neoplastic | 25.52 | |
Diabetic Angiopathies | 23.65 | |
Myocardial Ischemia | 23.4 | |
Diabetic nephropathy | 22.07 | |
Psoriasis | 21.97 | |
Drug-induced liver injury | 21.83 | |
Liver Cirrhosis, Experimental | 21.83 |